$SGNT Sagent Pharmaceuticals, Inc. Insider Trading Week 35/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sagent Pharmaceuticals, Inc. in week 35/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 34,961 | 760,402 | 0 | 35 K to 0 (-100.00 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures V, LLC | 10% Owner | Sell | U | 21.75 | 2,978,803 | 64,788,965 | 0 | 3 M to 0 (-100.00 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 17 | 230 | 25,320 | 25.3 K to 25.3 K (-0.07 %) |
Sep 01 2016 | SGNT | Sagent Pharmaceuti ... | Vivo Ventures VI, LLC | 10% Owner | Sell | S | 13.55 | 2,299 | 31,151 | 3,456,332 | 3.5 M to 3.5 M (-0.07 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.10 | 55,000 | 1,105,500 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 16.45 | 12,067 | 198,502 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 20.16 | 10,638 | 214,462 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | D | 14.61 | 34,783 | 508,180 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 27,206 | 591,731 | 0 | 27.2 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | U | 21.75 | 7,857 | 170,890 | 27,206 | 35.1 K to 27.2 K (-22.41 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Sell | D | 21.75 | 3,665 | 79,714 | 35,063 | 38.7 K to 35.1 K (-9.46 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Option Exercise | D | 14.61 | 108,696 | 1,588,049 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 92,527 | 2,012,462 | 0 | 92.5 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | OBERMAN ALLAN | Chief Executive Off ... | Sell | D | 21.75 | 9,459 | 205,733 | 92,527 | 102 K to 92.5 K (-9.27 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 11.60 | 6,379 | 73,996 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Sell | U | 21.75 | 7,097 | 154,360 | 0 | 7.1 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 2.51 | 607 | 1,524 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 4.23 | 6,870 | 29,060 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 4.31 | 5,103 | 21,994 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 11.60 | 5,103 | 59,195 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 16.45 | 9,969 | 163,990 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 20.16 | 3,546 | 71,487 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 14.61 | 6,522 | 95,286 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Option Exercise | D | 15.02 | 10,608 | 159,332 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Sell | D | 21.75 | 8,073 | 175,588 | 0 | 8.1 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BULLOCK DONALD R | Executive V.P. Sale ... | Sell | U | 21.75 | 2,583 | 56,180 | 8,073 | 10.7 K to 8.1 K (-24.24 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 11.60 | 6,379 | 73,996 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Sell | U | 21.75 | 7,097 | 154,360 | 0 | 7.1 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 11.60 | 5,103 | 59,195 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 760 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 433,770 | 9,434,498 | 0 | 433.8 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 2,000 | 43,500 | 0 | 2 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Sell | U | 21.75 | 8,050 | 175,088 | 0 | 8.1 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Gift | G | 0.00 | 4,150 | 0 | 8,050 | 12.2 K to 8.1 K (-34.02 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Devel ... | Option Exercise | D | 12.19 | 21,016 | 256,185 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | BRYNJELSEN SEAN | EVP, Business Devel ... | Sell | D | 21.75 | 9,844 | 214,107 | 0 | 9.8 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Option Exercise | D | 15.81 | 20,000 | 316,200 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Option Exercise | D | 14.61 | 10,507 | 153,507 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | D | 21.75 | 4,962 | 107,924 | 0 | 5 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | U | 21.75 | 600 | 13,050 | 0 | 600 to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | WARD MICHAEL V. | Chief Legal Off. an ... | Sell | U | 21.75 | 1,000 | 21,750 | 4,962 | 6 K to 5 K (-16.77 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 592 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 1,860 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 1,381 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 691 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Sell | U | 21.75 | 2,041 | 44,392 | 0 | 2 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Sell | D | 21.75 | 2,283 | 49,655 | 2,041 | 4.3 K to 2 K (-52.80 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Option Exercise | D | 13.46 | 18,897 | 254,354 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Harmon J Frank | EVP, Global Operati ... | Sell | D | 21.75 | 8,915 | 193,901 | 0 | 8.9 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 16.45 | 8,604 | 141,536 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 20.16 | 8,865 | 178,718 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | D | 14.61 | 10,507 | 153,507 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Sell | D | 21.75 | 4,962 | 107,924 | 0 | 5 K to 0 (-100.00 %) |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 2,228 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Option Exercise | D | 0.00 | 8,556 | 0 | 0 | |
Aug 31 2016 | SGNT | Sagent Pharmaceuti ... | Yanai Shlomo | Director | Sell | D | 21.75 | 742 | 16,139 | 0 | 742 to 0 (-100.00 %) |